Vitamin D3 for Life

Live Enlightened

Research libraryVitamin D3 For Life
Study design and methods

Secondary relevance to vitamin D This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.

This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.

Why this paper is included

Supporting source evidence:

Patient characteristics and correlation between femoral neck BMD and clinical parameters.n = 80mean (median) r p Sex Male, n (%)45 (56)0.417#< 0.001Age, years71 (60 to 76)-0.274#0.014HD duration, months74 (36 to 140)-0.111#0.325Past medical history and physical status, n (%)Diabetes mellitus29 (36)0.006#0.960Bone fracture24 (30)-0.312#0.005Difficulty of walking18 (23)-0.368#0.001Vital sign and physical findingsSystolic BP, mmHg156 ± 22-0.0070.952Diastolic BP, mmHg81 ± 150.1270.263Heart rate, /min72 ± 120.1230.276Body Mass Index, kg/m222.5 ± 3.90.448< 0.001Medication, n (%)Vitamin D analog62 (78)0.126#0.266Phosphate binder63 (79)-0.175#0.120Calcimimetics31 (39)0.027#0.814Laboratory findingsAlbumin, g/dL3.5 (3.3 to 3.8)0.139#0.219Serum sodium, mEq/L138 (136 to 140)-0.017#0.881Serum potassium, mEq/L5.0 ± 0.7-0.1410.214Serum calcium, mg/dL8.6 ± 0.7-0.1580.163Serum phosphate, mg/dL5.1 (4.4 to 6.1)0.148#0.190BUN, mg/dL63 ± 150.1320.244Cr, mg/dL10.6 ± 3.00.508< 0.001Hb, g/dL11.6 (10.9 to 12.0)0.059#0.601TSAT, %29.0 (20.7 to 35.9)-0.023#0.842Ferritin, ng/mL131 (59 to 236)-0.026#0.818Total cholesterol, mg/dL155 (130 to 183)0.053#0.642HDL cholesterol, mg/dL50 ± 14-0.1020.368Triglyceride, mg/dL99 (68 to 151)0.171#0.129HbA1c, %5.3 (4.9 to 5.8)0.251#0.025β2-microglobulin, mg/L27.9 ± 5.70.0150.895Intact PTH, pg/mL139 (98 to 190)0.108#0.339ALP, U/L252 (189 to 317)-0.060#0.600BAP, µg/L13.0 (10.6 to 15.8)-0.320#0.004TRACP-5b, mU/dL416 (294 to 656)-0.206#0.068Psoas Muscle Mass Index, cm2/m24.7 ± 1.30.504< 0.001Femoral neck BMD, g/cm20.55 ± 0.11--Abbreviations: BMD, bone mineral density; HD, hemodialysis; BP, blood pressure; BUN, blood urea nitrogen; Cr, creatinine; Hb, hemoglobin; TSAT, transferrin saturation; HDL, high density lipoprotein; PTH, parathyroid hormone; ALP, alkaline phosphatase; BAP, bone-specific alkaline phosphatase; TRACP-5b, tartrate-resistant acid phosphatase 5b.Categorical data are presented as number (%), while continuous data are presented as mean ± standard deviation or median (interquartile range).#Spearman’s rank correlation for skewed distributed data.

Source: Results. View original paper

Relevance classification does not establish study quality, causation or editorial approval.

Study design Study design awaiting verification.

Study design awaiting verification

The available source does not establish a sufficiently clear study design.

Meta-analysis unclear · Blinding unclear / not reported · Research setting awaiting verification

How this paper was classified

Automatic source-based classification; awaiting editorial verification. This is not a quality score.

View supporting evidence in the original paper

What the study types mean
Systematic review
Uses explicit methods to identify, assess and summarise research on a defined question.
Scoping review
Maps the extent and characteristics of research on a topic.
Narrative review
Discusses existing research; systematic-review methods have not been established by this classification.
Review / evidence synthesis
Reviews existing research; the exact review methods need further assessment.
Randomised controlled trial
Assigns participants or groups to comparison interventions by chance.
Non-randomised intervention study
Examines an intervention without random allocation.
Cohort study
Examines exposures and outcomes over time within a defined group.
Case-control study
Compares people with an outcome against people without it, examining exposures.
Cross-sectional study
Examines a population at a particular point in time.
Observational study
Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
Case report
Describes an individual case.
Case series
Describes a group of individual cases.
Secondary analysis
Analyses existing study data; this paper is not automatically another independent trial.
Laboratory study
Investigates biological processes in a laboratory setting.
Qualitative study
Examines experiences or meanings using qualitative methods.
Genetic instrumental-variable study
Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
Study protocol
Describes planned methods and is not evidence that the planned study has reported results.
Multiple reported designs
More than one design is explicitly reported; examine the supporting methods.
Study design awaiting verification
The available source does not establish a sufficiently clear study design.

Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.

Abstracts

Association between psoas muscle mass index and bone mineral density in patients undergoing hemodialysis

Study design awaiting verification · Scientific Reports · 2025

Original publication title

Association between psoas muscle mass index and bone mineral density in patients undergoing hemodialysis

Kiyonori Ito; Susumu Ookawara; Hidenori Sanayama; Hideo Kakuda; Chieko Kanai; Katsuo Iguchi; Mitsutoshi Shindo; Keisuke Tanno; Shun Ishibashi; Masafumi Kakei; Kaoru Tabei; Yoshiyuki Morishita

© The Author(s) 2024

Original publication · Publisher record · CC BY 4.0

Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.

At a glance

What does the authors’ abstract report?

Patients undergoing dialysis are at risk of osteoporosis and sarcopenia because of mineral and bone disorders or malnutrition. Additionally, maintaining muscle mass is important to prevent osteoporosis. The psoas muscle mass index (PMI) was recently used to evaluate muscle mass. However, few studies have evaluated the association between the PMI and bone mineral density (BMD); therefore, we examined the association between PMI and BMD in the femoral neck (FN) of 80 patients (45 males, age, 71 (60 to 76) years; dialysis duration, 74 (36 to 140) months) undergoing hemodialysis.

FN-BMD was measured using dual-energy X-ray absorptiometry, and PMI was evaluated using psoas muscle areas on computed tomography. FN-BMD and PMI were significantly higher in males than in females. In a correlation analysis, sex, BMI, serum creatinine levels, HbA1c levels, and PMI were positively correlated with FN-BMD, whereas age, history of bone fracture, difficulty in walking and bone-specific alkaline phosphatase level were negatively correlated. In the multivariate regression analysis using clinical factors significantly correlated to FN-BMD, including PMI, both sex (standardized coefficient: 0.249, p = 0.028) and PMI (standardized coefficient: 0.249, p = 0.038) were extracted.

Multivariable linear regression analysis using PMI and traditional osteoporosis factors revealed that PMI was significantly and independently associated with FN-BMD (standardized coefficient: 0.308, p = 0.010). In conclusion, PMI was positively associated with FN-BMD. Attention should be paid to the possibility of decreased BMD with decreased muscle mass.

Authors’ abstract

Patients undergoing dialysis are at risk of osteoporosis and sarcopenia because of mineral and bone disorders or malnutrition. Additionally, maintaining muscle mass is important to prevent osteoporosis. The psoas muscle mass index (PMI) was recently used to evaluate muscle mass. However, few studies have evaluated the association between the PMI and bone mineral density (BMD); therefore, we examined the association between PMI and BMD in the femoral neck (FN) of 80 patients (45 males, age, 71 (60 to 76) years; dialysis duration, 74 (36 to 140) months) undergoing hemodialysis.

FN-BMD was measured using dual-energy X-ray absorptiometry, and PMI was evaluated using psoas muscle areas on computed tomography. FN-BMD and PMI were significantly higher in males than in females. In a correlation analysis, sex, BMI, serum creatinine levels, HbA1c levels, and PMI were positively correlated with FN-BMD, whereas age, history of bone fracture, difficulty in walking and bone-specific alkaline phosphatase level were negatively correlated. In the multivariate regression analysis using clinical factors significantly correlated to FN-BMD, including PMI, both sex (standardized coefficient: 0.249, p = 0.028) and PMI (standardized coefficient: 0.249, p = 0.038) were extracted.

Multivariable linear regression analysis using PMI and traditional osteoporosis factors revealed that PMI was significantly and independently associated with FN-BMD (standardized coefficient: 0.308, p = 0.010). In conclusion, PMI was positively associated with FN-BMD. Attention should be paid to the possibility of decreased BMD with decreased muscle mass.

Publication and source details

Original title: Association between psoas muscle mass index and bone mineral density in patients undergoing hemodialysis

Kiyonori Ito; Susumu Ookawara; Hidenori Sanayama; Hideo Kakuda; Chieko Kanai; Katsuo Iguchi; Mitsutoshi Shindo; Keisuke Tanno; Shun Ishibashi; Masafumi Kakei; Kaoru Tabei; Yoshiyuki Morishita

Scientific Reports · 2025

© The Author(s) 20242024https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.The Kidney Foundation, JapanJKFB19-9

Repository JATS snapshot; version as supplied

Source retrieved: 2026-11-11T07:20:29.736565+00:00

DOI: 10.1038/s41598-024-84873-4 · PMC11696570